Sequoia Financial Advisors, LLC Athersys, Inc Transaction History

Sequoia Financial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.18 - $0.86 $12,438 - $59,427	69,102 Added 44.78%	223,407 $56,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $49,450 - $87,362	82,417 Added 114.65%	154,305 $94,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.4 $92,745 - $152,756	-109,112 Reduced 60.28%	71,888 $65,000
Q3 2021 Oct 26, 2021	BUY	$1.33 - $1.77 $53,200 - $70,800	40,000 Added 28.37%	181,000 $241,000
Q4 2020 Feb 12, 2021	BUY	$1.55 - $2.24 $1,550 - $2,240	1,000 Added 0.71%	141,000 $247,000
Q2 2020 Aug 11, 2020	BUY	$1.97 - $3.98 $39,400 - $79,600	20,000 Added 16.67%	140,000 $386,000
Q1 2020 May 11, 2020	BUY	$1.17 - $3.0 $17,550 - $45,000	15,000 Added 14.29%	120,000 $360,000
Q4 2019 Feb 13, 2020	BUY	$1.16 - $1.42 $28,999 - $35,500	25,000 Added 31.25%	105,000 $129,000
Q2 2019 Jul 31, 2019	BUY	$1.39 - $2.03 $20,850 - $30,449	15,000 Added 23.08%	80,000 $134,000
Q3 2018 Nov 14, 2018	BUY	$1.86 - $2.18 $46,500 - $54,500	25,000 Added 62.5%	65,000 $137,000
Q1 2018 May 14, 2018	BUY	$1.34 - $2.03 $16,080 - $24,359	12,000 Added 42.86%	40,000 $73,000
Q4 2017 Feb 13, 2018	BUY	$1.65 - $2.45 $46,200 - $68,600	28,000	28,000 $51,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.